trastuzumab,zanidatamab,tucatinib,fulvestrant
seagen,zymeworks,jazz
['sgntuc-019', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'zanidatamab', 'tucatinib', 'zanida']
promising data on her2-targeted therapies for biliary tract cancer presented at #asco23, from both the sgntuc-019 trial of tucatinib + trastuzumab and the herizon-btc-01 trial of zanidatamab (published in : 
The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.